HepaFat-AI is the only FDA, TGA and CE approved product on the market that can provide NASH-CRN Steatosis Grading, Proton Density Fat Fraction and Volumetric Liver Fat Fraction in a single patient report.
Recent announcements made by the company approvals allude to just how large the addressable market for HepaFat-AI is... Below is just one extract (each announcement alludes to varying opportunities from clinical trials to daily use by physicians for patient care):
'With an estimated global prevalence of between 24-30%, NAFLD affects up to 2.3 billion people, a figure expected to grow year-on-year. Of these, about 470 million people (or 20%) will develop NASH, an inflammatory condition of the liver, of which an estimated 27% will develop serious fibrotic, disease increasing their risk of cirrhosis, cancer and liver failure. Having surpassed viral hepatitis, NAFLD is now the leading cause of liver morbidity and mortality and the leading indicator for liver transplants in the US. It is predicted that over the next 10 years the healthcare costs associated with the management of NAFLD will exceed USD $1 trillion in the US and €334 billion in Europe (Germany, France, Italy, and the United Kingdom).'
Since regulatory approvals have been obtained, the company has been been marketing the HepaFat-AI solution, this also involves contacting customers of the FerriSmart products (of which there are over 200) to upsell the new HepaFat-AI solution.
As most with IT backgrounds would be aware, with all implementation, there is development effort (UAT/PVT) and training required for the acquirer to establish the interface and navigate the functionality of a new solution.
Seek.com.au show the company adding four additional roles to assist in the support of the increased workload that will come from HepaFat-AI.
The most interesting of these four roles is the Software Engineer, of which I have a screen capture below (HepaFat-AI is evident here)
I am picking RHT to be one of the best small cap buys of 2021.
All thoughts are mine. DYOR...
Add to My Watchlist
What is My Watchlist?
